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Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease 
of the central nervous system.  The core pathological process 
of MS is affection of the myelin coating of the nervous fibers. 
According to Milo, 2010 [1] there are about 2.5 million people 
worldwide suffering of MS.  This is the most common cause 
of neurologic disability in young and middle-aged adults.  It 
affects women twice as common than men.  The onset of the 
disease usually occurs between 20 and 50 years of age with a 
peak at about 30 years of age [2, 3].
Case presentation
A 62-year-old right-handed, married male was referred 
and admitted to the Department of Neurorehabilitation for a 
course of rehabilitation therapy.  On admission, he was alert, 
without particularities on physical examination: temperature 
36.8, pulse rate 74/minute regular, blood pressure 112/71 mm 
Hg, and respiratory rate 17/minute.  His higher mental func-
tions, including orientation, memory, judgement and abstract 
reasoning were normal.  Mini mental status examination 
(MMSE) revealed a score of 26/30.  The patient suffered of 
tetraparesis, flaccid in upper limbs and spastic in lower limbs. 
He also complained of urinary incontinence.  Functional in-
dependence measure (FIM) revealed a score of 38 points.  A 
blood test revealed elevated erythrocyte sedimentation rate 
(21 mm/hour) but was otherwise unremarkable.  His medical 
history revealed that ninety-two days prior to the current pre-
sentation, acute tetraplegia, disphagia and disphasia developed 
on the background of upper respiratory tract infection.  He, 
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Background: Although previously considered rare, nowadays there are a growing number of reports describing association of psychotic impairment 
and multiple sclerosis (MS).  Still, this connection remains unclear.  The etiology of psychosis in MS has also not been explained adequately.
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Conclusions: The present case report describes a psychotic impairment as an isolated clinical manifestation of the second onset of multiple sclerosis. 
The case demonstrates the importance in considering multiple sclerosis as a cause of acute or progressive severe cognitive impairment even with relative 
sparing of other neurological deficits.  We suggest that the acute psychosis that has been described in the case is associated with the lesions in frontobasal 
and periventricular area of temporoparietal region and pericallosal area.
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then, was admitted to an intensive care unit.  Magnetic reso-
nance imaging (MRI) of the brain and spinal cord revealed 
multiple focci of demyelinisation and gliosis.  A diagnosis of 
acute disseminated encephalomyelitis (ADEM) was made 
as per ICD 10.  The patient was treated with corticosteroid 
therapy (methylprednisolone). On the tenth day after the first 
admission an improvement was reported, plegia regressed to 
paresis as well as bulbar impairment was noticeably reduced. 
The patient was discharged on the fourteenth day.
After ninety-two days, in our Department the patient 
began a course of complex physiokinetotherapy and occu-
pational therapy.  In the first night after admission – the 
ninety-third day after the first admission – the patient woke 
up approximately at 1:15 a.m., he was agitated and aggressive 
till the morning.  During the evaluation on the next day the 
patient did not recollect the events of the previous night. 
He was assigned to Clonazepame 0.5 mg per day.  In the 
second night the patient complained of the lack of sleeping, 
irritability, anger outbursts.  He was muttering and gesticula-
ting to himself, he stressed his body was “possessed by dark 
forces”, he violently scratched his body, he misrecognised his 
relative persons.  An evaluation by the psychiatric service 
was requested. An acute delusional disorder was diagnosed. 
Clonazepame was replaced by Quetiapine at 50 mg/initiation 
dose with 50 mg/day dosage pace until a total dose of 200 mg 
per day was reached.
Taking into account psychotic disorder as possible re-
lapse of demyelinating disease, further investigations were 
undertaken. MRI scan of the spinal cord (fig. 1) and brain 
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(fig. 2, 3) revealed progression of focci of demyelinisation in 
paraventricular areas, frontal, temporal and occipital lobes, 
cerebellum.
Fig. 1.  MRI dorsal spine sagittal T2-weighted images.  Imaging 
made at the first presentation (A) and ninety-five days after (B). 
On image A the cervicomedullary lesion appears hyperintense 
at the level of cervical vertebrae II to VII.  On image B the lesion 
expands to cervical vertebra IX, showing dissemination  
in time and space.
Fig. 2.  MRI brain horizontal T2-weighted images.  Imaging 
made at the first presentation (A series images) and ninety-five 
days after (B series images).  On series A hyperintense lesions 
are depicted in frontal lobes (A1) and paraventricular regions 
(A2, A3).  On series B the lesions’ expanding is demonstrated 
in frontobasal lobes (B1), paraventricular and perviventricular 
regions (B3), occipital lobes (B2) and temporal lobes (B1).
Fig. 3.  MRI brain sagittal T2-weighted images.  Imaging made 
ninety-five days after the first presentation.  There are multiple 
hyperintense lesions in pericallosal area (A1, A2), occipital lobe 
(A2), temporal lobes (A3) and cerebellum (A3).
A diagnosis of multiple sclerosis, cerebro-spinal form, 
relapsing remitting pattern, EDSS 8.5 with tetraparesis, uri-
nary incontinence and mental disorders was established.  The 
patient was assigned to corticosteroid intravenous therapy.
Mental condition of the patient improved on the 3rd 
day after steroid therapy.  Delusional psychotic component 
decreased, though the patient remained depressive and apa-
tic.  Minimental state examination showed 13 points’ result. 
Neurological assessment on the discharge day (10th day after 
admission) revealed a slight improvement – FIM 45 points 
score.  His antipsychotic medication was continued in a dose of 
quetiapine 150 mg per day.  He was advised to attend cognitive 
rehabilitation.  The patient was followed up after a period of 
2 weeks wherein, improvement in psychotic symptoms was 
reported.
Discussion
The problem of psychiatric disorders associated with MS 
has not been adequately managed for a long time.  Meanwhi-
le, these disorders are very important in the formation of 
the clinical picture of the disease, and, sometimes they are 
the cause of diagnostic errors.  Recent years, an increasing 
attention of researchers has been marked.  Large-scale hospi-
tal-based, epidemiological and case studies have suggested a 
relationship between psychosis and MS through demonstra-
ting their higher than chance co-occurrence, their temporal 
relationship, and their association with particular structural 
abnormalities in the brain.  The characteristics of psychiatric 
disorders in MS may vary widely: from asthenic syndrome 
to severe dementia and psychotic state.  The most of reports 
of co-occurrence of psychosis and MS is uncommon, mos-
tly these are single case studies [4].  Mental impairment in 
MS was observed as often as in the general population, but 
a recent study reported rates of 2-3% compared with 0.5-
1% in the general population [5].  These disorders develop 
independently of the degree and nature of neurological 
deficit.  In some cases, mental disorders are the first and/or 
dominant symptom [6].  Currently, the factors that predict 
the development of cognitive impairment in an individual 
patient are not completely elucidated.  They have a significant 
effect on the performance and effectiveness of the treatment, 
often exacerbating the disability, but not always taken into 
account by the specialists.
Short psychotic episodes may occur as manifestations as 
well as a remission-followed onset relapse in MS.  The most 
severe, but rare mental disorder in MS is a polymorphic psy-
chotic state.  This condition may include a very wide range 
of psychopathological manifestations – from fragmentary 
perception to severe psychotic episode.  Such patients are 
more likely to be misdiagnosed as suffering of schizophrenia. 
Psychosis in MS distinctly differs from schizophrenia as it has 
a later age at onset, quicker resolution, fewer relapses, better 
response to treatment and a better prognosis [7].
It is important to stress, that, in almost all cases, signs of 
organic lesions of the nervous system are present.  The cause 
of diagnostic errors in such cases is the underestimation 
of neurological symptoms due to the prevalence of mental 
disorders, or insufficient tactics to detect these symptoms. 
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Patients with acute psychotic disorders in MS have a signi-
ficantly larger area of periventricular lesions, visualized on 
MRI, mainly in temporoparietal region [8], especially around 
temporal horns.  These findings were made in comparison 
with a group of MS patients with the same duration and se-
verity of disease [7].  In a dynamic study (9 months long) of 
glucose metabolism, made by positron emission tomography 
and MRI, in a patient with acute behavioral disorders and 
MS, a progressive decrease of the metabolism in the frontal 
and temporal cortex bilaterally was observed, as well as in 
thalamus and hippocampus, on the background of the rapid 
increase of the demyelinating lesions.  These results suggest 
that the basis for the development of mental disorders, per-
haps is a violation of subcortical neuronal interactions (due 
to demyelination and subsequent deafferentation), which led 
to metabolism impairment of the above laying cortex [9]. 
The scarce database on psychosis in MS suggests an invol-
vement of lesions in temporal areas [7, 10].  It may be related 
to a predominance of lesions in the temporal lobes [11, 12] 
and with larger lesions in general.  In all cases, neurological 
symptoms preceded the onset of psychosis.  The psychotic 
group also had a later age of onset of psychosis than psychotic 
patients without brain disease.  In another study, flattened 
affect, delusions and thought disorder were associated with 
greater pathology in the temporoparietal region in a sample 
of 116 MS patients compared with a control group with 
physical disabilities [13].
Neuropsychological testing of patients with multiple 
sclerosis is a complex task due to the wide range of possible 
cognitive impairment.  Large volume of testing often leads to 
rapid depletion of the patient.  In addition, some neuropsycho-
logical tests, such as correction test, cannot be performed at 
a patient, suffering from MS, because of neurological deficits 
(visual impairment, tremor etc.) or mild dementia.  The most 
commonly screening assessment, used for evaluation of these 
patients, is Mini Mental Status Examination (MMSE) [14] 
and Breaf Repeatable Battery of Neuropsychological Tests 
(BRB-N) [15].  BRB-N was designed specially for patients 
with MS, it considers the most common cognitive impairment 
associated with MS and the above mentioned difficulties in 
testing.  Its implementation takes a total of 20 minutes and 
does not require specially trained psychologist.  In the Repu-
blic of Moldova, similar tests for examination of the patients 
with MS have not been yet implemented.
Conclusion
Mental impairment may associate MS during the course 
of the disease or as a symptom of first onset.  Despite the fact, 
that modern neuroimaging techniques offer a greater insight 
into prevalence and pathophysiology of many psychometric 
findings associated with MS, the pathogenesis of these disor-
ders needs further research.
We suggest that the acute psychosis that has been described 
in the case is associated with the lesions in frontobasal and 
periventricular area of temporoparietal region and pericallosal 
area.  This localization correlates with most of the reports, 
relating coincidence of psychotic disorders with MS.
In the case neurological impairment preceded the onset 
of psychotic one, which also corresponds to most of reports. 
Notwithstanding, the peculiarity of the presented case is that 
the relapse of the disease was manifested by an uncommon 
MS clinical presentation characterized by an isolated severe 
psychotic disorder in the relative absence of significant pro-
gression of neurological deficit (fig. 4).
Fig. 4.  Clinical evolution of the disease.  At the first onset (day 1) the patient presented tetraplegia, bulbar disorders and urinary 
incontinence.  After steroid therapy, clinical symptoms were reduced to tetraparesis and urinary incontinence (day 14).  At the second 
onset (day 94) delusional psychosis was revealed. At discharge (day 102), after steroid and neuroleptics therapy, the patient presented 
moderate cognitive disorder.
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Despite the overwhelming presence of neurological MS 
symptoms, close attention should be paid to the early diagnosis 
and sufficient treatment of the psychiatric aspects.
The case demonstrates the importance in considering MS 
as a cause of acute or progressive severe cognitive impairment 
even with relative sparing of other neurological deficits.  Ge-
neral medical conditions should always be eliminated before 
diagnosing a primary psychiatric condition, especially in a 
patient with late-onset or atypical features, peripheral physical 
findings, a lack of response to standard treatments and cogniti-
ve changes.  Considering the insufficient number of controlled 
trials and tested algorithms for the particular population of 
psychiatrically affected MS patients, the current treatment 
should be based on general psychiatric treatment guidelines.
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